Retatrutide Dosing: Precision Administration for Triple-Agonist Peptide Research Mastering retatrutide dosing is fundamental to successful metabolic peptide research. As a triple-agonist compound simultaneously engaging GLP-1, GIP, and glucagon receptors, retatrutide requires sophisticated dosing strategies that account for its unique pharmacokinetic profile, receptor occupancy dynamics, and dose-dependent adverse event spectrum. Whether you’re designing preclinical protocols or…